Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Online-Only Emergency Contraception Option Works to Overcome Purchase Hurdles for Women
  • USA - English


News provided by

Robin Leedy & Associates

Nov 03, 2014, 06:00 ET

Share this article

Share toX

Share this article

Share toX

New AfterPill is Available Now
New AfterPill is Available Now

Women have told me that their local stores typically don’t carry a large supply of EC or don’t sell it at all, so it can be difficult to find when it’s needed fast

Post this

Westport, CT (PRWEB) November 03, 2014 -- Affordability and accessibility are two of the main hurdles women face when purchasing emergency contraception (EC). “I speak to many women on this topic annually, and just because emergency contraception is now allowed to be sold over-the-counter, it doesn’t mean the store carries the product, it can be found in stock, or that it’s at a price that’s affordable for many women. Brands in stores are almost $50 for one pill,” says Dawn Stacey, M.Ed., LMHC, the About.com contraception expert and new educational spokesperson for AfterPill™ (http://www.afterpill.com), a new online-only emergency contraception brand working to close the gap of EC affordability and access, allowing women to more easily plan ahead.

“Women have told me that their local stores typically don’t carry a large supply of EC or don’t sell it at all, so it can be difficult to find when it’s needed fast,” says Stacey, who advocates for being prepared and having EC on hand AHEAD of when you might need it. “EC has been shown to be most effective within the first 12 hours, so you want to make sure it’s accessible versus spending these hours searching for a store that carries EC or has it in stock.”

New AfterPill™, available at http://www.AfterPill.com, from Syzygy Healthcare Solutions, LLC, has made EC more affordable with a savings up to 60% off the leading retail brand – just $20 per pill and $5 shipping/handling – so there’s less of a financial hurdle to purchase it ahead in the event it’s eventually needed. Additionally, it is always in stock on the site, so accessibility, even for men purchasing for a partner, is never an issue.

In a recent peer-reviewed nationwide study, EC was not available on shelf in 51% of U.S. pharmacies. In another study, many men were prohibited from purchasing it on behalf of their partner. Considering more than 50% of Americans have said that they've had unprotected sex with a partner at least once, and with half of pregnancies unintended, Stacey believes having EC on hand is very important, and AfterPill can assist with this.

Stacey prompts, “Offering the best-selling, #1 doctor-recommended OTC emergency contraceptive medicine online at such a low price is really the first of its kind, and ensures a level of discretion and privacy, since it arrives in a non-descript package.” Stacey continues, “The dramatically lower price of AfterPill™ helps to eliminate a common cost barrier in proactive birth control planning.”

“It’s very hard to convince women to spend $50 to have a pill they might need,” explains Stacey, “yet, the World Health Organization, myself, and other women’s health advocates have long recommended that women have an emergency contraceptive on hand. At $20, new AfterPill™ makes that decision very easy for women.”

AfterPill™ is a Food and Drug Administration (FDA) authorized over-the-counter emergency contraceptive tablet (1.5 mg levonorgestrel) made in the U.S. for women ages 17 and older. For more information or to purchase, visit http://www.AfterPill.com.

About AfterPill™:

New AfterPill™ is an after-sex emergency birth control. When used quickly, it reduces the chance of becoming pregnant after unprotected sex or regular birth control failure. AfterPill™ contains 1.5mg of levonorgestrel, the best-selling and #1 doctor-recommended medicine for emergency contraception. It is the same medicine that has been used safely and effectively in regular birth control pills for 35 years and the same medicine in Plan B One-Step®. AfterPill™ is estrogen-free, made in the USA, and FDA authorized.

New AfterPill™ Emergency Contraceptive can be used effectively for up to 72 hours (3 days) after unprotected sex or birth control failure. It is more effective the sooner you use it, and it has been shown to be most effective when used within 12 hours following unprotected sex.

If you are already pregnant, new AfterPill™ will not work. It will not terminate or harm an existing pregnancy. While new AfterPill™ reduces the risk of pregnancy after unprotected sex or birth control failure, it will not impact your ability to become pregnant in the future.

Like all birth control pills, new AfterPill™ does not protect against HIV/AIDS or other sexually transmitted diseases.

Plan B One-Step® is a registered trademark of Women's Capital Corporation and marketed by Teva Women’s Health, Inc.

###

Alyson O'Mahoney, Robin Leedy & Associates, http://rlapr.com/, +1 (914) 241-0086 Ext: 13, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.